Main > ONCOLOGY (**) > Kidney Cancer>RCC>MET *** > Treatment > CH. N. Aldesleukin>***

---

CH. N. Aldesleukin>***'s subsections
(*) USA Approval Year: 1992
>(Recombinant IL-2) for Inj.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2007. 01.23
Patent>US Expiration: 2006. 05.05
TradeMark
TradeMark Web-Site

CH. N. Aldesleukin>***'s products
This section has no products